首页 > 专栏 > The Lancet Gastroenterology & Hepatology The Lancet Gastroenterology & Hepatology 共 31 条资讯 [Articles] Short-course prophylaxis with the Toronto HCV protocol for recipients of non-liver solid organ transplants from donors with hepatitis C viraemia: a retrospective, matched cohort study 2026-06-28 11:44:18 [Review] Pain management in chronic pancreatitis: beyond opioids 2026-06-28 11:44:18 [Articles] Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial 2026-06-28 11:44:18 [Comment] Lessons from the European LiverScreen and Chinese LiverHealth projects 2026-06-28 11:44:18 [Articles] Prevalence of liver fibrosis and steatotic liver disease in community-dwelling adults in China (the CHESS-LiverHealth project): cross-sectional baseline data from a prospective cohort study 2026-06-28 11:44:18 [Comment] Decompensation unmasks renal susceptibility in cirrhosis 2026-06-28 11:44:18 [Articles] Genetic variants and the risk of renal impairment in decompensated cirrhosis: a multi-ancestry genome-wide association study 2026-06-28 11:44:18 [Articles] Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial 2026-06-28 11:44:18 [Correspondence] Incidence of inflammatory bowel disease in Jakarta, Indonesia, 2021–24 2026-06-28 11:44:18 [Articles] Germline multigene panel testing for colorectal cancer: a systematic review and meta-analysis 2026-06-28 11:44:18 [Articles] On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial 2026-06-28 11:44:18 [Articles] ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial 2026-06-28 11:44:18 [Review] The trajectory of inflammatory bowel disease in east and southeast Asia: transitioning from acceleration in incidence to compounding prevalence 2026-06-28 11:44:18 [Comment] Propelling MASLD trials into the era of non-invasive tests 2026-06-28 11:44:18 [Review] Bowel endometriosis: from pathogenesis to clinical management 2026-06-28 11:44:18 [Review] Barrier restoration as a therapeutic strategy for disorders of gut–brain interaction 2026-06-28 11:44:18 [Articles] Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre, open-label, randomised controlled superiority trial 2026-06-28 11:44:18 [Review] Pathophysiology of irritable bowel syndrome 2026-06-28 11:44:18 [Articles] The glucagon and GLP-1 receptor dual agonist DD01 for metabolic dysfunction-associated steatotic liver disease and steatohepatitis (DD01-DN-02): 12-week results from a randomised, double-blind, multicentre, placebo-controlled, phase 2 trial 2026-06-28 11:44:18 [Comment] Launch of the Africa CDC toolkit for hepatitis B: bringing care closer to people in Africa 2026-06-28 11:44:18 12下一页 » 相关分类 The Lancet Gastroenterology & Hepatology Gastroenterology The Lancet #!/slash/note #UNTAG (B)(F)uzzing on my world (Hi)story (IN)SECURE Magazine Notification (gdb) break *0x972 - 带鱼博客 BeltfishBlog - ./kwaa.dev .NET Blog .Trash /home/rook1e 00's Adventure 0kami's Blog 0x41414141 in ?? () 0x7f Blog 0xRick Owned Root ! 0xd00's blog 1 Byte 1A23 Blog 1A23 Studio 1Link.Fun 1stwebdesigner 251 2BAB 的工程博客 2ch中文网 360 CERT 360 Netlab Blog - Network Securi